[Controlled ovarian stimulation protocols in endometriosis patients: with antagonist or agonist?]

Ya Yu, Yu Y, Kai Wei, Wei K, Yao Q, Qiuping Yao, Tian Shen, Shen Tian, Tian S, Kun Liang, Liang K, Zhou L, Liming Zhou, Wang L, Liping Wang, Min Jin, Jin M
Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2019 · vol. 48(2) , pp. 165–173 · doi:10.3785/j.issn.1008-9292.2019.04.07 · PMID:31309754 · PMC8800656 · W2973657383
article OA: green CC0 ⤵ 4 in-corpus citations
📄 Open PDF Full text JSON View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-09 ⓘ

This study compared IVF outcomes in endometriosis patients using antagonist, long agonist, or prolonged agonist protocols, finding the antagonist protocol comparable to agonist protocols, especially for diminished ovarian reserve.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-07, 2026-07-09 · read from full text ⓘ

The paper discusses controlled ovarian stimulation protocols in endometriosis patients, comparing outcomes under antagonist versus agonist approaches for ovarian stimulation. It addresses which protocol is preferable in this patient population, presenting the comparative findings reported in the underlying clinical context. A major limitation explicitly reflected in the presentation is that the article content shown in the provided text is largely administrative and does not include detailed methods, results, or a stated evidence-based limitation. This paper is centrally about endometriosis — it focuses on how antagonist versus agonist controlled ovarian stimulation protocols are managed and compared in endometriosis patients.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

OBJECTIVE: fertilization-embryo transfer (IVF-ET) in patients with endometriosis using antagonist protocol, long agonist protocol or prolonged agonist protocol. METHODS: Totally 313 patients with endometriosis were recruited in Reproductive Centers of the Second Affiliated Hospital of Zhejiang University School of Medicine,Jiaxing Women and Children's Hospital,and Ningbo Women and Children's Hospital from April 2017 to October 2018, including 81 patients treated with antagonist protocol (antagonist group), 148 treated with long agonist protocol (long agonist group) and 84 treated with prolonged agonist protocol (prolonged agonist group). The clinical and laboratory data of the patients were retrospectively analyzed to investigate the effect of ovarian stimulation protocols on the IVF-ET outcomes of patients with endometriosis. RESULTS: <0.05). CONCLUSIONS: Patients with endometriosis who used the antagonist protocol in IVF procedure could reduce the cost and time of Gn treatment, when combined with frozen-embryo transfer strategy the antagonist protocol has comparable clinical pregnancy outcome with long or prolonged agonist protocol, especially in those with diminished ovarian reserve, the higher available embryo rate can be achieved.
Full text 1,389 characters · extracted from oa-doi-fallback · click to expand
× SciEngine Journals & Books JOURNALS BOOKS CART CUSTOMER 中文 LOGIN Search SciEngine AI Intelligent Search Advanced Search LOG IN TO SciEngine Account Login Get verification code Forget the password Get code Sign in Register reset password Reset password link has been sent to your mailbox. Please check it in the mailbox. Print ISSN : 1008-9292 Online ISSN : 2097-5171 CN : 33-1248/R Open Access Content Menus Advanced Search Home Browse Latest Issue Archive Author Center Ethical Guidelines Scopes & Requirement for Submission Instructions to Authors Download Center Editorial Board About About Journal Journal policies Open Access Copyright and Licensing Contact us News Editorial Notice Home Browse Latest Issue Archive Author Center Ethical Guidelines Scopes & Requirement for Submission Instructions to Authors Download Center Editorial Board About About Journal Journal policies Open Access Copyright and Licensing Contact us News Editorial Notice Advanced Search × Add new Menu Name English Chinese URL Sort Jump Way _self _blank × Update Menu Name English Chinese URL Sort Jump Way _self _blank {{lang == 'en_US' ? 'This article has been Discontinue.' : '该文章已下架。'}} BACK TO TOP TOP × Company Info Chinese Company Info Integrated Info Register System Info Waiting... Interesting search NetworkPositioning Search results View all results from this journal/book Top 5 Related Articles

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometriosis Ovulation Induction Ovulation Induction Embryo Transfer Female Fertilization in Vitro Humans Pregnancy Retrospective Studies

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (23)

Cited by (4)

Source provenance

europepmc
last seen: 2026-08-17T06:11:01.428247+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:22:41.077124+00:00
License: CC0 · commercial use OK